Neurophet Signs MOU with ALZ-NET to Facilitate Imaging Monitoring Infrastructure for Alzheimer's Disease Therapies

---
Neurophet Signs MOU with ALZ-NET to Facilitate Imaging Monitoring Infrastructure for Alzheimer's Disease Therapies
Vote:
0 0
Previous Addentax Group Corp. Announces Reverse Stock Split
Next HealYou Built a Mental Health Platform for the Millions of Asians Who Would Never Use One

Related News

Neurophet receives FDA 510(k) Clearance for Neurophet AQUA

Neurophet and The Florey Strengthen Research Collaboration on 'Neurophet AQUA' to Advance Alzheimer's Disease Diagnosis

Neurophet Participates in BIO USA 2025: To showcase Brain Imaging Analysis Solutions Including 'Neurophet AQUA AD'

Neurophet Secures FDA 510(k) Clearance for "Neurophet AQUA AD Plus," Marking Its Third U.S. Regulatory Milestone

Neurophet Participates ASNR 2025: Showcasing Clinical Utility of 'Neurophet AQUA AD'

Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of 'Neurophet AQUA AD'

menu
menu